Company / Cash per Share
Bio-Rad Laboratories Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$18.14
FY2025
5-year range
$13.37 / $18.14
FY2021-FY2025
Trend
+10.7%
vs FY2024
Sector context
#16 of 146
Health Care
What the data says
Bio-Rad Laboratories's cash per share of $18.14 is higher than 89% of companies in the Health Care sector (FY2025). Cash per Share has fluctuated over the past 10 years, ranging from $12.95 in FY2018 to $22.00 in FY2019.
Based on SEC 10-K filings.
18.14 in FY2025 with a 5-year CAGR of -3.7%. Top quartile in the Health Care sector.
Improved from $13.37 to $18.14 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +8.0%
- 5-Year CAGR
- -3.7%
- 10-Year CAGR
- -
Sector benchmark
-34.5% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 10.7% year-over-year.
- Ranks #16 out of 146 companies in the Health Care sector.
- Peak cash per share was recorded in FY2019.
- Lowest cash per share in the period was in FY2018.
Company context
Key Data Points
- Strong return on equity: 23.0%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $18.14 | +10.7% |
| FY2024 | $16.39 | +22.6% |
| FY2023 | $13.37 | -7.1% |
| FY2022 | $14.40 | -7.7% |
| FY2021 | $15.60 | -28.6% |
| FY2020 | $21.86 | -0.6% |
| FY2019 | $22.00 | +69.9% |
| FY2018 | $12.95 | -16.5% |
| FY2017 | $15.51 | +9.4% |
| FY2016 | $14.18 | -10.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026